Earnings Feed
Start Free
Home/Filings/4/0001127602-24-028486
4//SEC Filing

Mandadi Tilak 4

Accession 0001127602-24-028486

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 5:13 PM ET

Size

8.1 KB

Accession

0001127602-24-028486

Insider Transaction Report

Form 4
Period: 2024-11-30
CVS HEALTH CorpCVS
Mandadi Tilak
EVP, Chief Experience & Tech
Transactions
  • Award

    Common Stock (RSU)

    2024-11-30$59.85/sh+50,125$2,999,981→ 99,747 total
Holdings

  • Stock Option

    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (96,496 underlying)
    96,496

  • Common Stock

    40,414

  • Stock Option

    Exercise: $79.56From: 2025-04-01Exp: 2034-04-01→ Common Stock (67,920 underlying)
    67,920
Footnotes (3)
  • [F1]Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 11/30/2025.
  • [F2]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.
  • [F3]Option becomes exercisable in four equal annual installments, commencing 4/1/2025.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001872827

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:13 PM ET
Size
8.1 KB
View on SEC.gov